LEADIANT BIOSCIENCES Trademark

Trademark Overview

On Thursday, March 17, 2016, a trademark application was filed for LEADIANT BIOSCIENCES with the United States Patent and Trademark Office. The USPTO has given the LEADIANT BIOSCIENCES trademark a serial number of 86943755. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Monday, October 17, 2022. This trademark is owned by Sigma-Tau Rare Disease Limited. The LEADIANT BIOSCIENCES trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the respiratory system, the musculoskeletal system, the genitourinary system, for the treatment of nephrological disorders, inflammatory disorders, cancer and rare diseases, for use in dermatology, in hematology, in oncology, in transplantation, in ophthalmology, for use in gastroenterological areas and the prevention and treatment of ocular disorders or diseases; dietary supplements for humans and animals
leadiant biosciences

General Information

Serial Number86943755
Word MarkLEADIANT BIOSCIENCES
Filing DateThursday, March 17, 2016
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateMonday, October 17, 2022
Registration Number5179368
Registration DateTuesday, April 11, 2017
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 24, 2017

Trademark Statements

NOT AVAILABLE"BIOSCIENCES"
Goods and ServicesPharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the respiratory system, the musculoskeletal system, the genitourinary system, for the treatment of nephrological disorders, inflammatory disorders, cancer and rare diseases, for use in dermatology, in hematology, in oncology, in transplantation, in ophthalmology, for use in gastroenterological areas and the prevention and treatment of ocular disorders or diseases; dietary supplements for humans and animals
Certificate of Correction for RegistrationIn the statement, line 1, "Sigma-Tau Rare Disease Limited" should be deleted and "Leadiant Biosciences Limited" should be inserted.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, March 22, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameLEADIANT BIOSCIENCES LIMITED
Party Type30 - Original Registrant
Legal Entity Type24 - NOT AVAILABLE
AddressLondon EC1A2DY
GB
Party NameLEADIANT BIOSCIENCES LIMITED
Party Type20 - Owner at Publication
Legal Entity Type24 - NOT AVAILABLE
AddressLondon EC1A2DY
GB
Party NameSigma-Tau Rare Disease Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressLondon EC1A2DY
GB

Trademark Events

Event DateEvent Description
Monday, March 21, 2016NEW APPLICATION ENTERED
Tuesday, March 22, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, June 28, 2016ASSIGNED TO EXAMINER
Wednesday, July 20, 2016NON-FINAL ACTION WRITTEN
Wednesday, July 20, 2016NON-FINAL ACTION E-MAILED
Wednesday, July 20, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, November 3, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, November 22, 2016ASSIGNED TO LIE
Wednesday, November 30, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, November 30, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, December 2, 2016EXAMINERS AMENDMENT -WRITTEN
Friday, December 2, 2016EXAMINERS AMENDMENT E-MAILED
Friday, December 2, 2016NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, December 2, 2016EXAMINER'S AMENDMENT ENTERED
Tuesday, December 6, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, December 19, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, January 4, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, January 11, 2017ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, January 24, 2017PUBLISHED FOR OPPOSITION
Tuesday, January 24, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 11, 2017REGISTERED-PRINCIPAL REGISTER
Friday, May 12, 2017TEAS SECTION 7 REQUEST RECEIVED
Monday, July 3, 2017ASSIGNED TO PARALEGAL
Thursday, July 6, 2017POST REGISTRATION ACTION CORRECTION
Monday, July 17, 2017OTQR WITHDRAWAL FROM PUBLICATION
Tuesday, August 1, 2017CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, September 11, 2017POST REGISTRATION ACTION MAILED - SEC. 7
Monday, September 18, 2017TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Wednesday, February 28, 2018CORRECTION UNDER SECTION 7 - PROCESSED
Monday, April 11, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, April 14, 2022TEAS SECTION 8 & 15 RECEIVED
Wednesday, October 12, 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, October 17, 2022REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Monday, October 17, 2022NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Tuesday, December 2, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, December 2, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, December 2, 2025TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Tuesday, December 2, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED

Related Keywords

biosciences leadiant system disorders treatment diseases prevention ophthalmology transplantation hematology dermatology gastroenterological